FORBES-TATE

Lobbying for GILEAD SCIENCES, INC. · Specialty biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $90,000.00 income · posted Apr 18, 2026

Lobbying activity 1

Health Issues

Issues related to healthcare, including improving patient access to advanced immunology therapies; Issues related to policies affecting biopharma products pricing, coverage and access in Medicare and Medicaid; Issues related to funding for HIV and HCV screening, linkage to care and treatment; Issues related to breast cancer screening.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.